Literature DB >> 371881

Facilitation reaction (enhancing antibodies and suppressor cells) and rejection reaction (sensitized cells) from the mother to the paternal antigens of the conceptus.

G Chaouat, G A Voisin, D Escalier, P Robert.   

Abstract

Humoral and cellular immune agents of a maternal reaction were investigated during pregnancy. Fluorescence studies performed on mouse placentae at 14 days detected maternal immunoglobulins of mainly IgG1 but also IgG2 subclasses. These immunoglobulins, after acid elution, can rebind the placenta and the thymocytes of the relevant paternal strain in case of allogeneic pregnancies, demonstrating an antibody activity towards both placenta specific and paternal strain antigens. They can specifically enhance a paternal strain tumour allograft on a maternal strain recipient. Spleen cells from an allogeneically pregnant mother can reduce or promote paternal strain tumour allograft on a maternal strain recipient. The aggressive effect is shown with small doses of transferred cells, whereas large doses promote enhancement. The suppression of the cytotoxic response of the recipient was ascribed to T cells by use of anti-theta plus complement. Thus, both the rejection reaction (immune cytotoxic cells) and the facilitation reaction (enhancing antibodies and suppressor cells) were demonstrated during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 371881      PMCID: PMC1537606     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Regulation of the immune response by subclasses of T lymphocytes. I. Interactions between pre-killer T cells and regulatory T cells obtained from peripheral lymphoid tissues of mice.

Authors:  H Cantor; E Simpson
Journal:  Eur J Immunol       Date:  1975-05       Impact factor: 5.532

2.  IMMUNE RESPONSE ENGENDERED IN MICE BY MULTIPARITY.

Authors:  N KALISS; M K DAGG
Journal:  Transplantation       Date:  1964-05       Impact factor: 4.939

3.  Role of suppressor cells in antibody-induced inhibition of mixed lymphocyte reactions.

Authors:  C Kanellopoulos-Langevin; J Kanellopoulos; G A Voisin
Journal:  Ann Immunol (Paris)       Date:  1976 Sep-Oct

4.  Attempts to demonstrate an in vivo role for serum blocking factors in tolerant mice.

Authors:  L Brent; C Brooks; N Lubling; A V Thomas
Journal:  Transplantation       Date:  1972-09       Impact factor: 4.939

5.  Inhibitory effect of human chorionic gonadotrophin on lymphocyte blastogenic response to mitogen, antigen and allogeneic cells.

Authors:  T Han
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

6.  alpha-Fetoprotein induces suppressor T cells in vitro.

Authors:  R A Murgita; E A Goidl; S Kontianen; H Wigzell
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

7.  Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression.

Authors:  M V Doyle; D E Parks; W O Weigle
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

8.  Characteristics of the maternal lymphoid response of mice to paternal strain antigens induced by homologous pregnancy.

Authors:  M G Baines; E A Speers; H Pross; K G Millar
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

9.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

10.  The adoptive transfer of pregnancy-induced unresponsiveness to male skin grafts with thymus-dependent cells.

Authors:  R N Smith; A E Powell
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  18 in total

1.  Maternal regulator cells during murine pregnancy.

Authors:  G Smith
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

Review 2.  Single-Cell Immunobiology of the Maternal-Fetal Interface.

Authors:  Derek Miller; Valeria Garcia-Flores; Roberto Romero; Jose Galaz; Roger Pique-Regi; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2022-10-15       Impact factor: 5.426

Review 3.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

4.  Regulatory T-cell subpopulations in pregnancy. II. Evidence for suppressive activity of the late phase of MLR.

Authors:  G Chaouat; G A Voisin
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

5.  Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infections in mice.

Authors:  B J Luft; J S Remington
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

6.  Self-specific memory regulatory T cells protect embryos at implantation in mice.

Authors:  Ting Chen; Guillaume Darrasse-Jèze; Anne-Sophie Bergot; Tristan Courau; Guillaume Churlaud; Karina Valdivia; Jack L Strominger; Maria Grazia Ruocco; Gérard Chaouat; David Klatzmann
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

7.  Syngeneic immune-dependent abortions in mice suggest paternal alloantigen-independent mechanisms.

Authors:  Jean A Kundert; Amy L Sealey; Yan Li; Mario R Capecchi; Edward E Schmidt
Journal:  Am J Reprod Immunol       Date:  2008-10       Impact factor: 3.886

Review 8.  Maintaining T cell tolerance of alloantigens: Lessons from animal studies.

Authors:  Kortney A Robinson; William Orent; Joren C Madsen; Gilles Benichou
Journal:  Am J Transplant       Date:  2018-08       Impact factor: 8.086

9.  Regulatory T cells in pregnancy. III. Comparison of early acting and late acting suppressor T cells in MLR: evidence for involvement of differential T-cell subsets.

Authors:  G Chaouat; G A Voisin
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

Review 10.  The Th1/Th2 paradigm: still important in pregnancy?

Authors:  Gérard Chaouat
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.